Global Registration Pathways for China's Novel Pesticides

The event featured insights from more than 30 speakers on pesticide innovation, global registration, market access, supply chains, and cross-border collaboration. Dr. Huang examined the data, regulatory, and partnership-model challenges facing China-developed novel pesticides as companies move beyond product exports toward coordinated registrations across international markets, and outlined an approach built around earlier action, sharper decisions, and stronger collaboration.

Dr. Huang's presentation followed a launch ceremony marking what the organizers described as the "Inaugural Year of Global Expansion for China's Innovative Pesticides." The timing placed this vision for China-developed novel pesticides in a practical business context: once a novel molecule has been developed, how can it achieve regulatory and commercial acceptance across international markets?

From Selling Products to Building Global Assets

Dr. Huang noted that Chinese agrochemical companies are moving beyond generics, manufacturing, and exports. As more proprietary active ingredients are developed in China, the central question is shifting from whether a product can be manufactured to whether it can secure regulatory and commercial acceptance across international markets.

Before embarking on international development, companies need to answer three questions: Can the existing data support registration in the intended target market? Is that market commercially worth entering? Can external partners clearly understand and evaluate the product's value?

Completing registration in China does not mean that the same dossier can be used directly in other jurisdictions. Chinese registration dossiers are generally prepared around domestic requirements, while overseas authorities often evaluate applications under OECD Test Guidelines, Good Laboratory Practice (GLP) principles, and jurisdiction-specific review frameworks. The earlier a company plans for international development, the greater its opportunity to identify gaps in study design, critical endpoints, data quality, and scientific interpretation.

"Safety data should not be viewed merely as a final-stage registration requirement; they should inform early-stage decisions about the international development of a novel pesticide," Dr. Huang emphasized. By treating safety evidence, registration data packages, and explanations of critical risks as reusable data assets, companies can more effectively translate efficacy, patent position, and market potential into value for multi-market registration and external partnerships.

PFAS and TFA: How Safety Risks Are Reshaping Market Priorities

Against growing regulatory attention to per- and polyfluoroalkyl substances (PFAS), Dr. Huang examined the potential implications of trifluoroacetic acid (TFA) for the international registration of fluorinated pesticides.

Regulatory definitions and scopes for PFAS vary across jurisdictions, and fluorinated pesticides should not automatically be equated with legacy high-concern PFAS such as PFOS and PFOA. For pesticide registration, a more immediate question is whether some fluorinated active ingredients may form TFA, which has relatively high environmental persistence and mobility. This could extend regulatory attention beyond the parent active substance to metabolites, as well as potential risks to groundwater and drinking water.

In Europe, work on toxicological reference values for TFA, harmonized classification, and its behavior in soil and water remains ongoing. Dr. Huang cautioned that companies must distinguish among requirements already in force, assessment procedures still in progress, and values that remain in draft form or under discussion. Regulatory signals should not be presented as final conclusions before the relevant processes are complete.

PFAS-related considerations—particularly TFA—along with metabolite profiles, carcinogenicity, and endocrine-disrupting properties may all alter market prioritization and sequencing for a novel pesticide. A global registration strategy should not assume simultaneous filings across all markets. A more practical approach is to begin in markets where existing data are more likely to be accepted by regulators and review pathways are clearer, then expand stepwise into higher-value or more demanding markets as the data package is evaluated and refined.

From Out-Licensing to Global Registration: Closing Capability Gaps Through Partnerships

The pesticide and pharmaceutical industries both involve high investment, long development timelines, and substantial technical risk. The pharmaceutical industry's more established experience with out-licensing and co-development therefore offers useful points of reference for developers of China's novel pesticides.

However, the pharmaceutical model cannot simply be replicated in agrochemicals. Pharmaceutical development centers largely on clinical value and patient benefit, whereas pesticide assessment places substantial weight on toxicology, environmental fate, ecotoxicology, residues, and risks under actual conditions of use. Strong efficacy and a compelling commercial proposition cannot be converted into registration value if the safety data do not support registration in the intended market.

Given the complexity of international pesticide registration, channel development, and local application practices, collaborative market entry may be a more practical approach for many developers of China-developed novel pesticides. Potential structures include regional licensing, co-development, registration partnerships, supply arrangements combined with market development, and phased cooperation models. Partnerships can supplement a developer's capabilities in overseas registration, distribution, and local commercialization, while allowing the parties to expand geographic rights and deepen cooperation as technical and commercial evidence accumulates.

Safety risk should also form part of early business development and product valuation. Product value is determined not only by efficacy, pest-control spectrum, and patent position, but also by target-market size, regulatory acceptance of existing data, major regulatory uncertainties, the likely cost of additional studies, and the allocation of development responsibilities between partners.

"Out-licensing is not an end in itself; it is a practical route toward coordinated registration and commercialization across international markets," Dr. Huang said. "What developers of China's novel pesticides bring to global partners should be more than a single product: it should be the combined value of the product, its regulatory data package, a robust development program, and the capability to build and manage partnerships."

Three Recommendations for Developers of China's Novel Pesticides

Addressing the main challenges in international development, Dr. Huang offered three recommendations:

• Act earlier: front-load safety risk assessment. Potential concerns involving metabolites, carcinogenicity, endocrine disruption, and PFAS-related issues—particularly those involving TFA—should be considered during project initiation and early international planning, alongside an assessment of gaps between Chinese and overseas data requirements. The later a material risk is identified, the greater the cost of additional studies and the more cautious prospective partners are likely to become.

• Make sharper decisions: use evidence to guide market prioritization and sequencing. Market selection should not be based only on which jurisdiction appears cheaper or faster. Companies should assess the potential to reuse existing data, market value, regulatory uncertainty, and opportunities for subsequent geographic expansion. Wherever possible, the core data package should be designed for use across multiple markets, with local efficacy, residue, and market-specific risk data added where required.

• Strengthen collaboration: assemble global capabilities across the value chain. The international development of a novel pesticide rarely depends on one company alone. Pesticide developers, seed companies, laboratories, consulting organizations, and overseas partners may all need to contribute, bringing the proprietary molecule, GLP data, crop systems and use programs, market sequencing, and partnership structure into one coherent development plan.

Supporting the Global Development of China's Novel Pesticides

REACH24H's contribution at CPEW 2026 highlighted the company's work in pesticide safety assessment, global regulatory intelligence, and international pesticide registration.

As a specialist provider of global agrochemical compliance services, REACH24H continues to monitor pesticide regulations and PFAS-related regulatory developments across major markets. The company supports clients from early safety risk identification, dossier gap assessment, and study planning through target-market prioritization, global registration strategy, and the communication of partnership value.

REACH24H will continue to combine scientific evidence with international regulatory expertise to support the global development of China's novel pesticides. By helping companies identify critical risks before major investment decisions, build data packages that can support multiple markets, and present a clearer technical and commercial case to prospective partners, REACH24H aims to turn compliance into a competitive advantage for Chinese innovation in global markets.

How REACH24H Can Help

REACH24H provides end-to-end regulatory support for the global development of China's novel pesticides:

• China registration.

  New pesticide registration and pre-registration safety assessment, aligning domestic dossiers for international expansion.

• Regulatory intelligence.

  Continuous tracking of PFAS, TFA, and metabolite requirements—including China's new pesticide metabolite evaluation standards—to identify critical data needs early.